Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NYSE - Delayed Quote USD

International Flavors & Fragrances Inc. (IFF)

Compare
76.48
-1.70
(-2.17%)
At close: March 28 at 4:00:02 PM EDT
76.16
-0.32
(-0.42%)
Pre-Market: 5:02:21 AM EDT
Loading Chart for IFF
  • Previous Close 78.18
  • Open 78.18
  • Bid --
  • Ask 79.50 x 1000
  • Day's Range 76.38 - 78.49
  • 52 Week Range 76.38 - 106.77
  • Volume 930,275
  • Avg. Volume 1,690,423
  • Market Cap (intraday) 19.559B
  • Beta (5Y Monthly) 1.23
  • PE Ratio (TTM) 80.51
  • EPS (TTM) 0.95
  • Earnings Date May 5, 2025 - May 9, 2025
  • Forward Dividend & Yield 1.60 (2.09%)
  • Ex-Dividend Date Mar 21, 2025
  • 1y Target Est 99.58

International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and markets food, beverage, health and biosciences, scent, pharma solutions, and complementary adjacent products in the United States, Europe, and internationally. It operates in four segments Nourish, Health & Biosciences, Scent, and Pharma Solutions. The Nourish segment consists of portfolio of natural-based ingredients that includes plant-based specialty food ingredients, such as soy and pea protein with value-added formulations, emulsifiers, and sweeteners; food protection ingredients, including natural antioxidants, and anti-microbials for natural food preservation and shelf-life extension; savory solutions, such as spices, marinades, and mixtures; combining flavourings with fruits, vegetables, and other natural ingredients products; a range of flavor compounds used in savory products, such as soups, sauces, meat, fish, poultry, and snacks; and beverages juice drinks, carbonated or flavored beverages, and spirits, as well as sweets bakery products, candy, cereal, and chewing gum; and dairy products, such as yogurt, ice cream, and cheese, as well as spices and seasoning ingredients. Its Health & Biosciences is comprised of health, cultures and food enzymes, home and personal care, animal nutrition, and grain processing. The Scent segment creates fragrance compounds, and fragrance ingredients. Its Pharma Solutions segment produces cellulosics and seaweed-based pharmaceutical excipients. The company was incorporated in 1909 and is headquartered in New York, New York.

www.iff.com

22,400

Full Time Employees

December 31

Fiscal Year Ends

Recent News: IFF

View More

Performance Overview: IFF

Trailing total returns as of 3/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

IFF
9.09%
S&P 500 (^GSPC)
5.11%

1-Year Return

IFF
9.47%
S&P 500 (^GSPC)
6.22%

3-Year Return

IFF
35.99%
S&P 500 (^GSPC)
21.97%

5-Year Return

IFF
20.56%
S&P 500 (^GSPC)
119.59%

Compare To: IFF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: IFF

View More

Valuation Measures

Annual
As of 3/28/2025
  • Market Cap

    19.56B

  • Enterprise Value

    28.68B

  • Trailing P/E

    80.51

  • Forward P/E

    17.76

  • PEG Ratio (5yr expected)

    1.78

  • Price/Sales (ttm)

    1.70

  • Price/Book (mrq)

    1.41

  • Enterprise Value/Revenue

    2.50

  • Enterprise Value/EBITDA

    17.95

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.12%

  • Return on Assets (ttm)

    1.51%

  • Return on Equity (ttm)

    1.73%

  • Revenue (ttm)

    11.48B

  • Net Income Avi to Common (ttm)

    243M

  • Diluted EPS (ttm)

    0.95

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    469M

  • Total Debt/Equity (mrq)

    69.16%

  • Levered Free Cash Flow (ttm)

    -999.75M

Research Analysis: IFF

View More

Company Insights: IFF

Research Reports: IFF

View More

People Also Watch